Procalcitonin in Diagnosis of Bacterial Infections in Young Infants

NCT03509727 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2018-04-26

No results posted yet for this study

Summary

A diagnostic accuracy study investigating the accuracy of procalcitonin in diagnosing invasive bacterial infections in your infants.

Conditions

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    lead OTHER

Principal Investigators

  • Michael Shields · Queen's University, Belfast

Eligibility

Max Age
90 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-01-01
Completion
2018-01-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03509727 on ClinicalTrials.gov